By |2021-07-30T14:06:04+03:00October 21st, 2020|PET/CT|

Glucose is the main energy supplier of the brain. Therefore the uptake of FDG is high, especially in the cortex, thalamus and striatum. Glucose metabolism in the brain is impaired in many neurological disorders which can therefore be diagnosed with FDG PET-CT. Furthermore FDG-PET can be used to localize the functional deficit zone

FDG PET/CT for Inflammation and Infection

By |2021-07-30T14:05:43+03:00October 21st, 2020|PET/CT|

FDG PET/CT is a noninvasive diagnostic imaging procedure providing tomographic images for the determination of localized metabolic activity. Cells involved in infection and inflammation, are able to express high levels of glucose transporters. The ability of the procedure to identify sites of inflammation and infection is related to the glycolytic activity of the

FDG PET/CT in Oncology

By |2021-07-30T14:05:15+03:00October 21st, 2020|PET/CT|

FDG PET/CT has been proven as a sensitive imaging modality for detection, staging and restaging and therapy response assessment in oncology. FDG PET/CT provides essential information for radiation treatment planning, helping with critical decisions when delineating tumour volumes. ❰❰ PATIENTS INSTRUCTIONS • This procedure requires exposure

Positron Emission Tomography (PET)

By |2021-07-30T13:42:59+03:00June 26th, 2014|PET/CT|

The combination of modalities is called hybrid imaging, and it is done to obtain fused images of the patient that are used in the diagnosis of tumors, infections, heart diseases, and others by combining a Positron Emission Tomography machine with a Computed Tomography machine in one device. Each of the two devices provides different

Go to Top